BACKGROUND: We evaluated the risk of death for health-care workers (HCW) with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Mexico City during the coronavirus disease 2019 (COVID-19) pandemic, and describe the associated factors in hospitalized HCW, compared with non-HCW. METHODS: We analyzed data from laboratory-confirmed SARS-CoV-2 cases registered from 27 February-31 August 2020 in Mexico City's public database. Individuals were classified as non-HCW or HCW (subcategorized as physicians, nurses, and other HCW). In hospitalized individuals, a multivariate logistic regression model was used to analyze the potential factors associated with death and compare mortality risks among groups. RESULTS: A total of 125 665 patients were included. Of these, 13.1% were HCW (28% physicians, 38% nurses, and 34% other HCW). Compared with non-HCW, HCW were more frequently female, were younger, and had fewer comorbidities. Overall, 25 771 (20.5%) were treated as inpatients and 11 182 (8.9%) deaths were reported. Deaths in the total population (9.9% vs 1.9%, respectively; P < .001) and in hospitalized patients (39.6% vs 19.3%, respectively; P < .001) were significantly higher in non-HCW than in HCW. In hospitalized patients, using a multivariate model, the risk of death was lower in HCW in general (odds ratio [OR], 0.53) than in non-HCW, and the risks were also lower by specific occupation (OR for physicians, 0.60; OR for nurses, 0.29; OR for other HCW 0.61). CONCLUSIONS: HCW represent an important proportion of individuals with SARS-CoV-2 infection in Mexico City. While the mortality risk is lower in HCW compared to non-HCW, a high mortality rate in hospitalized patients was observed in this study. Among HCW, nurses had a lower risk of death compared to physicians and other HCW.
BACKGROUND: We evaluated the risk of death for health-care workers (HCW) with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in Mexico City during the coronavirus disease 2019 (COVID-19) pandemic, and describe the associated factors in hospitalized HCW, compared with non-HCW. METHODS: We analyzed data from laboratory-confirmed SARS-CoV-2 cases registered from 27 February-31 August 2020 in Mexico City's public database. Individuals were classified as non-HCW or HCW (subcategorized as physicians, nurses, and other HCW). In hospitalized individuals, a multivariate logistic regression model was used to analyze the potential factors associated with death and compare mortality risks among groups. RESULTS: A total of 125 665 patients were included. Of these, 13.1% were HCW (28% physicians, 38% nurses, and 34% other HCW). Compared with non-HCW, HCW were more frequently female, were younger, and had fewer comorbidities. Overall, 25 771 (20.5%) were treated as inpatients and 11 182 (8.9%) deaths were reported. Deaths in the total population (9.9% vs 1.9%, respectively; P < .001) and in hospitalized patients (39.6% vs 19.3%, respectively; P < .001) were significantly higher in non-HCW than in HCW. In hospitalized patients, using a multivariate model, the risk of death was lower in HCW in general (odds ratio [OR], 0.53) than in non-HCW, and the risks were also lower by specific occupation (OR for physicians, 0.60; OR for nurses, 0.29; OR for other HCW 0.61). CONCLUSIONS: HCW represent an important proportion of individuals with SARS-CoV-2 infection in Mexico City. While the mortality risk is lower in HCW compared to non-HCW, a high mortality rate in hospitalized patients was observed in this study. Among HCW, nurses had a lower risk of death compared to physicians and other HCW.
Authors: César Pineda-Santoyo; Abraham Campos-Romero; Marco A Luna-Ruiz Esparza; Liliana E López-Luna; Martha E Sánchez-Zarate; Abraham Zepeda-González; Miguel A Fernández-Rojas; Jonathan Alcántar-Fernández Journal: Int J Environ Res Public Health Date: 2021-11-10 Impact factor: 3.390
Authors: Maximiliano Servin-Rojas; Antonio Olivas-Martinez; Fernando Ramirez Del Val; Armando Torres-Gomez; Luis Navarro-Vargas; Ignacio García-Juárez Journal: Am J Transplant Date: 2021-09-15 Impact factor: 9.369
Authors: Daniela de la Rosa-Zamboni; Fernando Ortega-Riosvelasco; Nadia González-García; Ana Estela Gamiño-Arroyo; Guillermo Alejandro Espinosa-González; Juan Manuel Valladares-Wagner; Araceli Saldívar-Flores; Olivia Aguilar-Guzmán; Juan Carlos Sanchez-Pujol; Briseida López-Martínez; Mónica Villa-Guillén; Israel Parra-Ortega; Lourdes María Del Carmen Jamaica-Balderas; Juan José Luis Sienra-Monge; Ana Carmen Guerrero-Díaz Journal: Front Pediatr Date: 2022-06-09 Impact factor: 3.569
Authors: Cheng-Wei Liu; Nivethika Jeyakumar; Eric McArthur; Jessica M Sontrop; Daniel T Myran; Kevin L Schwartz; Manish M Sood; Peter Tanuseputro; Amit X Garg Journal: CMAJ Open Date: 2022-07-19
Authors: Arthur Arantes Cunha; Rodolfo Antonio Corona; João Silvestre Silva-Junior; Emerson Augusto Castilho-Martins Journal: Rev Bras Med Trab Date: 2022-03-30
Authors: César Esquivel-Chirino; Yolanda Valero-Princet; Luis Alberto Gaitán-Cepeda; Carlos Hernández-Hernández; Alejandro Macías Hernández; Hugo Laparra-Escareño; José Luis Ventura-Gallegos; Delina Montes-Sánchez; Ambar Lopéz-Macay; Fernando Hernández-Sánchez; William Alves de Oliveira; José Antonio Morales-González; Daniela Carmona-Ruiz; Karol Rosen-Esquivel; Alejandro Zentella-Dehesa Journal: Medicina (Kaunas) Date: 2021-12-10 Impact factor: 2.430